The Value of Online CME in the Multidisciplinary Care of Patients with NTRK Fusion-Positive Thyroid Cancer

被引：0
|
作者：
Worst, M. A. [1 ]
Carothers, A. [1 ]
Surducan, M. [1 ]
Sipos, J. [2 ]
Wirth, L. [3 ]
机构：
[1] Medscape LLC, New York, NY USA
[2] Arthur G James Comprehens Canc Ctr, Columbus, OH USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 112卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
187
引用
收藏
页码：E50 / E51
页数：2
相关论文
共 50 条
  • [21] The effect of an online micro CE/CME on the multidisciplinary care of patients with nonmelanoma skin cancer
    Worst, Michelle Arielle
    Small, Andrew
    Middleton, Deborah
    Yamaguchi, Yoji
    Yuan, Meng
    Bahra, Sukhbir
    Patel, Vishal A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Entrectinib in NTRK fusion-positive (NTRK-fp) breast cancer: Updated data from STARTRK-2
    Lu, J.
    Blakely, C. M.
    Barve, M.
    Chung, C. H.
    Waqar, S. N.
    Hu, X.
    Delord, J-P.
    Krzakowski, M. J.
    Yonemori, K.
    Chen, D. T.
    Klingbiel, D.
    Heinzmann, S.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S204 - S205
  • [23] Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours
    Bazhenova, L.
    Liu, S. V.
    Lin, J. J.
    Lu, S.
    Drilon, A.
    Chawla, S. P.
    Fakih, M.
    Krzakowski, M.
    Paz-Ares, L.
    Blakely, C.
    Buchschacher, G. L., Jr.
    Cassier, P.
    Fan, Y.
    Folprecht, G.
    McCallum, S.
    Pitcher, B.
    Chen, D.
    Freund, R.
    Springfeld, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S598 - S599
  • [24] NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy
    Haratake, Naoki
    Seto, Takashi
    CLINICAL LUNG CANCER, 2021, 22 (01) : 1 - 5
  • [25] Entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis
    Garrido-Laguna, I.
    Lonardi, S.
    Bazhenova, L.
    Peeters, M.
    Longo, F.
    Sigal, D.
    Conkling, P.
    Duffaud, F.
    Klingbiel, D.
    Bordogna, W.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S370 - S371
  • [26] Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers
    Syed, Abdul Rehman
    Gorana, Aakash
    Nohr, Erik
    Yuan, Xiaoli-Kat
    Amin, Parthiv
    Ghaznavi, Sana
    Lamb, Debbie
    Mcintyre, John
    Eszlinger, Markus
    Paschke, Ralf
    EUROPEAN THYROID JOURNAL, 2024, 13 (03)
  • [27] Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases
    John, T.
    Chiu, C-H.
    Cho, B. C.
    Fakih, M.
    Farago, A. F.
    Demetri, G. D.
    Goto, K.
    Doebele, R. C.
    Siena, S.
    Drilon, A.
    Patel, M. R.
    Liu, S. V.
    Ahn, M-J.
    Bazhenova, L.
    Overbeck, T. R.
    Nieva, J.
    Kim, S-W.
    Veronese, L.
    Day, B-M.
    De Braud, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S397 - S398
  • [28] Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors
    Demetri, George D.
    De Braud, Filippo
    Drilon, Alexander
    Siena, Salvatore
    Patel, Manish R.
    Cho, Byoung Chul
    Liu, Stephen, V
    Ahn, Myung-Ju
    Chiu, Chao-Hua
    Lin, Jessica J.
    Goto, Koichi
    Lee, Jeeyun
    Bazhenova, Lyudmila
    John, Thomas
    Fakih, Marwan
    Chawla, Sant P.
    Dziadziuszko, Rafal
    Seto, Takashi
    Heinzmann, Sebastian
    Pitcher, Bethany
    Chen, David
    Wilson, Timothy R.
    Rolfo, Christian
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1302 - 1312
  • [29] Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors or ROS1-Positive NSCLC with CNS Metastases
    Paz-Ares, Luis
    Dziadziuszko, Rafal
    Drilon, Alexander
    John, Thomas
    Krebs, Matthew
    Demetri, George
    Shaw, Alice T.
    Siena, Salvatore
    Wolf, Juergen
    Farago, Anna F.
    Simmons, Brian
    Pitcher, Bethany
    Huang, Xinhui
    Doebele, Robert
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 235 - 235
  • [30] Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases
    Paz-Ares, L.
    Dziadziuszko, R.
    Drilon, A.
    John, T.
    Krebs, M.
    Demetri, G.
    Shaw, A.
    Siena, S.
    Wolf, J.
    Farago, A.
    Simmons, B.
    Ye, C.
    Huang, X.
    Doebele, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S305 - S305
12345